Glucose‐lowering agents for treating pre‐existing and new‐onset diabetes in kidney transplant recipients

BACKGROUND: Kidney transplantation is the preferred form of kidney replacement therapy for patients with end‐stage kidney disease (ESKD) and is often complicated by worsening or new‐onset diabetes. Management of hyperglycaemia is important to reduce post‐transplant and diabetes‐related complications...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cochrane Database Syst Rev
Hlavní autoři: Lo, Clement, Jun, Min, Badve, Sunil V, Pilmore, Helen, White, Sarah L, Hawley, Carmel, Cass, Alan, Perkovic, Vlado, Zoungas, Sophia
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley & Sons, Ltd 2017
Témata:
Medicine General & Introductory Medical Sciences
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6464265/
https://ncbi.nlm.nih.gov/pubmed/28238223
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD009966.pub2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky